FM
IRWD icon

Forward Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Forward Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-29,850
Closed -$400K – 344
2015
Q1 		$400K Sell
29,850
-412,972
-93% -$5.42M 0.02% 258
2014
Q4 		$5.02M Buy
442,822
+150,893
+52% +$1.73M 0.27% 57
2014
Q3 		$3.3M Buy
291,929
+235,423
+417% +$2.7M 0.2% 77
2014
Q2 		$705K Buy
+56,506
New +$614K 0.04% 192

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Forward Management's IRWD Position: Q2 2015 in Review

Forward Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2015, closing a stake of 29,850 shares — an estimated $400K sold.

Forward Management first reported a position in IRWD in Q2 2014 and held it in 4 quarters. The position peaked at $5.02M in Q4 2014. 137 funds tracked by Wall St. Rank hold IRWD as of Q2 2015.

  • Forward Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Forward Management sold 29,850 Ironwood Pharmaceuticals shares in Q2 2015, an estimated $400K.
  • Forward Management first reported a position in Ironwood Pharmaceuticals in Q2 2014 and held it in 4 quarters.
  • Forward Management's Ironwood Pharmaceuticals position peaked at $5.02M in Q4 2014.
  • 137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2015.

Based on Forward Management's 13F filing for Q2 2015, filed 11 Aug 2015.